IRCT20191030045275N1尚未招募2 期
Efficacy and Safety of moxidectin versus ivermectin for treatment of human scabies: A randomized clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 60 years（—）
- 性别
- All
入选标准
- •(A) Clinical: 1. Intense pruritus especially at night. 2. Typical distribution of the excoriated papulovesicular lesions; around umbilicus, flexures, genitalia, interdigital spaces. 3. Affection of other family members.
- •(B) Parasitological: By detection of Sarcoptes Scabeii mites (adult, larvae and eggs) in cutaneous scrapings.
排除标准
- •Patients with recent topical or systemic treatments of scabies.
- •Patients with clinical bacterial infection or any other associated skin disease.
- •Patients with any evident systemic diseases causing pruritus.
- •Pregnant and lactating women.
研究者
相似试验
已完成
不适用
Efficacy of a moxidectin versus ivermectin in subjects infected by Strongyloides stercoralisStrongyloides stercoralis infectionInfections and InfestationsISRCTN11983645Swiss Tropical and Public Health Institute (Swiss TPH)120
已完成
3 期
Moxidectin for LF, Cote d'Ivoire (DOLF)Lymphatic FilariasisNCT04410406Washington University School of Medicine164
已完成
3 期
Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus InfectionOnchocerciasisNCT00790998Medicines Development for Global Health1,497
已完成
2 期
Evaluating the effect of Ivermectin on covid 19 patientsCOVID 19.Corona virus infection, unspecifiedU07.1IRCT20200404046937N4Ahvaz University of Medical Sciences60
已完成
1 期
Efficacy and safety of Ivermectin for the treatment of Plasmodium falciparum infections in asymptomatic Gabonese adultsMalariaPACTR201908520097051Centre de Recherches Medicales de Lambarene49